These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 3446185

  • 21. The effect of sulfation on the anticoagulant and antithrombin III-binding properties of a heparin fraction with low affinity for antithrombin III.
    Schoen P, Wielders S, Petitou M, Lindhout T.
    Thromb Res; 1990 Feb 01; 57(3):415-23. PubMed ID: 2315894
    [Abstract] [Full Text] [Related]

  • 22. Structure of the antithrombin-binding site in heparin.
    Lindahl U, Bäckström G, Höök M, Thunberg L, Fransson LA, Linker A.
    Proc Natl Acad Sci U S A; 1979 Jul 01; 76(7):3198-202. PubMed ID: 226960
    [Abstract] [Full Text] [Related]

  • 23. Action of heparin on thrombin-antithrombin reaction.
    Machovich R, Blaskó G, Pálos LA.
    Biochim Biophys Acta; 1975 Jan 30; 379(1):193-200. PubMed ID: 1115795
    [Abstract] [Full Text] [Related]

  • 24. Structure and antithrombin-binding properties of heparin isolated from the clams Anomalocardia brasiliana and Tivela mactroides.
    Pejler G, Danielsson A, Björk I, Lindahl U, Nader HB, Dietrich CP.
    J Biol Chem; 1987 Aug 25; 262(24):11413-21. PubMed ID: 3624220
    [Abstract] [Full Text] [Related]

  • 25. Two-dimensional affinity resolution electrophoresis demonstrates that three distinct heparin populations interact with antithrombin III.
    Edens RE, Fromm JR, Fromm SJ, Linhardt RJ, Weiler JM.
    Biochemistry; 1995 Feb 28; 34(8):2400-7. PubMed ID: 7873519
    [Abstract] [Full Text] [Related]

  • 26. High and low anticoagulant activity heparins. Preparation in large scale and degree of complexation with antithrombin III.
    Takahashi HK, Nader HB, Dietrich CP.
    Arzneimittelforschung; 1985 Feb 28; 35(11):1620-3. PubMed ID: 4091864
    [Abstract] [Full Text] [Related]

  • 27. Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration.
    Collen D, Schetz J, de Cock F, Holmer E, Verstraete M.
    Eur J Clin Invest; 1977 Feb 28; 7(1):27-35. PubMed ID: 65284
    [Abstract] [Full Text] [Related]

  • 28. Probing the heparin-binding domain of human antithrombin III with V8 protease.
    Liu CS, Chang JY.
    Eur J Biochem; 1987 Sep 01; 167(2):247-52. PubMed ID: 3305015
    [Abstract] [Full Text] [Related]

  • 29. The molecular-weight-dependence of the anti-coagulant activity of heparin.
    Laurent TC, Tengblad A, Thunberg L, Höök M, Lindahl U.
    Biochem J; 1978 Nov 01; 175(2):691-701. PubMed ID: 743219
    [Abstract] [Full Text] [Related]

  • 30. Studies on the neutralizing mechanism of antithrombin activity of heparin by protamine.
    Okajima Y, Kanayama S, Maeda Y, Urano S, Kitani T, Watada M, Nakagawa M, Ijichi H.
    Thromb Res; 1978 Nov 01; 24(1-2):21-9. PubMed ID: 7330836
    [No Abstract] [Full Text] [Related]

  • 31. Heparin proteoglycans synthesized by mouse mastocytoma contain chondroitin sulphate.
    Lidholt K, Eriksson I, Kjellén L.
    Biochem J; 1995 Oct 01; 311 ( Pt 1)(Pt 1):233-8. PubMed ID: 7575459
    [Abstract] [Full Text] [Related]

  • 32. Interaction of heparin with myosin ATPase: possible involvement with the hemorrhagic activity and a correlation with antithrombin III high affinity-heparin molecules.
    Tersariol IL, Dietrich CP, Nader HB.
    Thromb Res; 1992 Nov 01; 68(3):247-58. PubMed ID: 1471071
    [Abstract] [Full Text] [Related]

  • 33. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.
    Hovingh P, Piepkorn M, Linker A.
    Biochem J; 1986 Jul 15; 237(2):573-81. PubMed ID: 2948492
    [Abstract] [Full Text] [Related]

  • 34. Location of the antithrombin-binding sequence in the heparin chain.
    Oscarsson LG, Pejler G, Lindahl U.
    J Biol Chem; 1989 Jan 05; 264(1):296-304. PubMed ID: 2909522
    [Abstract] [Full Text] [Related]

  • 35. Enhancement by heparin of thrombin-induced antithrombin III proteolysis: its relation to the molecular weight and anticoagulant activity of heparin.
    Marciniak E, Gora-Maslak G.
    Thromb Res; 1982 Nov 01; 28(3):411-21. PubMed ID: 7179225
    [Abstract] [Full Text] [Related]

  • 36. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M, Petersen LC, Thorsen S.
    J Lab Clin Med; 1984 Aug 01; 104(2):245-56. PubMed ID: 6747440
    [Abstract] [Full Text] [Related]

  • 37. Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration.
    Andersson LO, Barrowcliffe TW, Holmer E, Johnson EA, Sims GE.
    Thromb Res; 1976 Dec 01; 9(6):575-83. PubMed ID: 1006626
    [No Abstract] [Full Text] [Related]

  • 38. Chromatography of heparin on sepharose-lysine: molecular size fractionation and its relevance to thrombin and antithrombin III binding.
    Hatton MW, Berry LR, Kaur H, Koj A, Regoeczi E.
    Can J Biochem; 1979 Oct 01; 57(10):1183-90. PubMed ID: 120212
    [No Abstract] [Full Text] [Related]

  • 39. Inhibitory activities for thrombin and factor Xa of whale heparin: comparative studies on two preparations from different species.
    Ototani N, Yosizawa Z.
    Tohoku J Exp Med; 1986 Sep 01; 150(1):77-82. PubMed ID: 3775773
    [Abstract] [Full Text] [Related]

  • 40. Interaction of heparin with histidine-rich glycoprotein and with antithrombin III.
    Lijnen HR, van Hoef B, Collen D.
    Thromb Haemost; 1983 Aug 30; 50(2):560-2. PubMed ID: 6415849
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.